TipRanks
RedHill Biopharma (DE:2RH)
FRANKFURT:2RH
Germany Market
2RH
RedHill Biopharma
RESEARCH TOOLSreports

RedHill Biopharma (2RH) Stock News & Sentiment

5 Followers
RedHill Biopharma Reshapes GI Portfolio With Asset Sale and New Licensing Deals
Premium
Company Announcements
RedHill Biopharma Reshapes GI Portfolio With Asset Sale and New Licensing Deals
13h ago
6K
RDHL
RedHill Biopharma Reshapes GI Portfolio With Rebyota, Clenpiq Deal and Talicia Sale
Premium
Company Announcements
RedHill Biopharma Reshapes GI Portfolio With Rebyota, Clenpiq Deal and Talicia Sale
13h ago
6K
RDHL
RedHill Biopharma Pushes for Growth Securing Rights to Ferring’s $37M Gastrointestinal Drugs Portfolio
Premium
Market NewsSponsored
RedHill Biopharma Pushes for Growth Securing Rights to Ferring’s $37M Gastrointestinal Drugs Portfolio
23d ago
JNJ
LLY
RedHill Sells its Talicia® H. pylori Drug Business to Apotex in $18M Deal to Fuel Growth
Premium
Market NewsSponsored
RedHill Sells its Talicia® H. pylori Drug Business to Apotex in $18M Deal to Fuel Growth
30d ago
GS
LLY
RedHill Biopharma Inks 13-Year Global Deal for Ferring’s Rebyota and U.S. Rights to Clenpiq
Premium
Company Announcements
RedHill Biopharma Inks 13-Year Global Deal for Ferring’s Rebyota and U.S. Rights to Clenpiq
30d ago
6K
RDHL
RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring’s Rebyota® and Clenpiq®
Premium
TipRanks Newswire
RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring’s Rebyota® and Clenpiq®
30d ago
RDHL
Why Is Penny Stock RedHill Biopharma (RDHL) Up 103% Today?
Premium
Market News
Why Is Penny Stock RedHill Biopharma (RDHL) Up 103% Today?
1M ago
APTX
CPIX
More DE:2RH News >

2RH News on the Web

RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring’s Rebyota® and Clenpiq®
TipRanks News
Bullish
RedHill announces acquisition of commercialization rights to Rebyota, Clenpiq
TipRanks News
Bullish
RedHill acquires exclusive commercialization rights to Rebyota, Clenpiq for $12M
TipRanks News
Bullish
RedHill announces divestment of Talicia business to Apotex Health subsidiary
TipRanks News
Bullish
RedHill Divests Talicia® to Apotex for $18 Million Cash Upfront Plus Milestones to Fuel Strategic Growth Opportunities
TipRanks News
Bullish
RedHill Biopharma Sells Talicia Stake to Apotex for $18 Million Upfront
TipRanks News
Neutral
RedHill Biopharma Reschedules 2026 AGM to Add Proposal, Seeks Approval to Scrap Par Value
TipRanks News
Neutral
RedHill Biopharma Expands ATM ADS Offering Capacity in U.S. Market
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
DE:2RH
Sector Average
Media Buzz
This Week2 articles
Weekly Average3 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:2RH’s Media Buzz Sentiment?
2 articles about DE:2RH were published this week. In an average week, 3 articles are published.
    What is DE:2RH’s weekly average amount of articles?
    In an average week, 3 articles about DE:2RH are published.
      What is DE:2RH’s News Sentiment?
      50% of articles about DE:2RH were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        SMMTSummit Therapeutics
        CDNACareDx
        ARGXArgenx Se
        MEOBFMesoblast Limited
        KODKodiak Sciences
        Showing the stocks with the most bullish news sentiment over the past week